Radiotherapy combination opportunities leveraging immunity for the next oncology practice - PubMed (original) (raw)
Review
doi: 10.3322/caac.21358. Epub 2016 Aug 29.
Affiliations
- PMID: 27570942
- DOI: 10.3322/caac.21358
Free article
Review
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Fernanda G Herrera et al. CA Cancer J Clin. 2017 Jan.
Free article
Abstract
Approximately one-half of patients with newly diagnosed cancer and many patients with persistent or recurrent tumors receive radiotherapy (RT), with the explicit goal of eliminating tumors through direct killing. The current RT dose and schedule regimens have been empirically developed. Although early clinical studies revealed that RT could provoke important responses not only at the site of treatment but also on remote, nonirradiated tumor deposits-the so-called "abscopal effect"- the underlying mechanisms were poorly understood and were not therapeutically exploited. Recent work has elucidated the immune mechanisms underlying these effects and has paved the way for developing combinations of RT with immune therapy. In the wake of recent therapeutic breakthroughs in the field of immunotherapy, rational combinations of immunotherapy with RT could profoundly change the standard of care for many tumor types in the next decade. Thus, a deep understanding of the immunologic effects of RT is urgently needed to design the next generation of therapeutic combinations. Here, the authors review the immune mechanisms of tumor radiation and summarize the preclinical and clinical evidence on immunotherapy-RT combinations. Furthermore, a framework is provided for the practicing clinician and the clinician investigator to guide the development of novel combinations to more rapidly advance this important field. CA Cancer J Clin 2017;67:65-85. © 2016 American Cancer Society.
Keywords: T cells; abscopal effect; fractionation; immunotherapy; inflammation; radiotherapy.
© 2016 American Cancer Society.
Similar articles
- The immune mechanisms of abscopal effect in radiation therapy.
Grass GD, Krishna N, Kim S. Grass GD, et al. Curr Probl Cancer. 2016 Jan-Feb;40(1):10-24. doi: 10.1016/j.currproblcancer.2015.10.003. Epub 2015 Nov 21. Curr Probl Cancer. 2016. PMID: 26612692 Review. - [Abscopal effect: Myth or reality?].
Mirjolet C, Truc G. Mirjolet C, et al. Cancer Radiother. 2021 Oct;25(6-7):533-536. doi: 10.1016/j.canrad.2021.07.002. Epub 2021 Aug 28. Cancer Radiother. 2021. PMID: 34462213 Review. French. - Combining radiotherapy and immunotherapy: a revived partnership.
Demaria S, Bhardwaj N, McBride WH, Formenti SC. Demaria S, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66. doi: 10.1016/j.ijrobp.2005.06.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 16199306 Free PMC article. Review. - Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
Ko EC, Formenti SC. Ko EC, et al. Int J Radiat Biol. 2019 Jul;95(7):936-939. doi: 10.1080/09553002.2019.1623429. Epub 2019 Jun 13. Int J Radiat Biol. 2019. PMID: 31120369 Review. - Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y, Dong Y, Kong L, Shi F, Zhu H, Yu J. Liu Y, et al. J Hematol Oncol. 2018 Aug 16;11(1):104. doi: 10.1186/s13045-018-0647-8. J Hematol Oncol. 2018. PMID: 30115069 Free PMC article. Review.
Cited by
- Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review).
Kuang G, Wang Z, Luo C, Luo J, Wang J. Kuang G, et al. Int J Oncol. 2023 Jan;62(1):2. doi: 10.3892/ijo.2022.5450. Epub 2022 Nov 11. Int J Oncol. 2023. PMID: 36367187 Free PMC article. - Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
Li Z, Zhang Y, Hong W, Wang B, Chen Y, Yang P, Zhou J, Fan J, Zeng Z, Du S. Li Z, et al. Gut Microbes. 2022 Jan-Dec;14(1):2119055. doi: 10.1080/19490976.2022.2119055. Gut Microbes. 2022. PMID: 36093568 Free PMC article. - Advances in Radiobiology of Stereotactic Ablative Radiotherapy.
Qiu B, Aili A, Xue L, Jiang P, Wang J. Qiu B, et al. Front Oncol. 2020 Aug 7;10:1165. doi: 10.3389/fonc.2020.01165. eCollection 2020. Front Oncol. 2020. PMID: 32850333 Free PMC article. Review. - Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME).
Alimohammadi M, Ghaffari-Nazari H, Alimohammadi R, Bakhshandeh M, Jalali SA, Rezaei N. Alimohammadi M, et al. Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):209-215. doi: 10.18502/ajmb.v15i4.13490. Avicenna J Med Biotechnol. 2023. PMID: 38078341 Free PMC article. Review. - Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity.
Chen D, Barsoumian HB, Fischer G, Yang L, Verma V, Younes AI, Hu Y, Masropour F, Klein K, Vellano C, Marszalek J, Davies M, Cortez MA, Welsh J. Chen D, et al. J Immunother Cancer. 2020 Jun;8(1):e000289. doi: 10.1136/jitc-2019-000289. J Immunother Cancer. 2020. PMID: 32581056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources